Skip to search formSkip to main contentSkip to account menu

ebastine

Known as: 4-diphenylmethoxy-1-(3-(4-tert-butylbenzoyl)propyl)piperidine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Simultaneous Equation Method for simultaneous estimation of Ebastine and Montelukast sodium in combined tablet dosage form has… 
2012
2012
Histamine HI receptor antagonists are the drugs of choice in the treatment of seasonal allergic rhinitis (SAR). Compared with… 
2003
2003
A simple and precise second derivative UV spectrophotometric method (A) and colorimetric method (B) were developed for the… 
2003
2003
A simple and sensitive spectrophotometric method employing acid-dye technique was developed for the estimation of ebastine in… 
2002
2002
Placebo-controlled outdoors clinical study was performed at the Utsunomiya City Forest Park surrounded by many cryptomerias on… 
Review
2002
Review
2002
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2001
2001
The purpose of the study was to elucidate human intestinal cytochrome P450 isoform(s) involved in the metabolism of an… 
1999
1999
Ebastine is a nonsedating and selective histamine H1 receptor antagonist without anticholinergic or sedative effects at… 
1995
1995
BACKGROUND Ebastine is a nonsedating histamine H-1 antagonist undergoing evaluation for treatment of allergic rhinitis and… 
1995
1995
SummaryThe efficacy and safety of the nasally administered histamine H1 receptor blocking drug azelastine was investigated in a…